Intra-Cellular Therapies Statistics
Total Valuation
FRA:COG has a market cap or net worth of EUR 1.66 billion. The enterprise value is 4.85 billion.
Market Cap | 1.66B |
Enterprise Value | 4.85B |
Important Dates
The last earnings date was Tuesday, July 8, 2025.
Earnings Date | Jul 8, 2025 |
Ex-Dividend Date | Jul 29, 2025 |
Share Statistics
Current Share Class | 30.11M |
Shares Outstanding | n/a |
Shares Change (YoY) | -2.37% |
Shares Change (QoQ) | +0.00% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 29.95M |
Valuation Ratios
The trailing PE ratio is 7.92 and the forward PE ratio is 8.63.
PE Ratio | 7.92 |
Forward PE | 8.63 |
PS Ratio | 0.88 |
PB Ratio | 0.71 |
P/TBV Ratio | n/a |
P/FCF Ratio | 4.32 |
P/OCF Ratio | 2.17 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.28, with an EV/FCF ratio of 12.63.
EV / Earnings | 23.14 |
EV / Sales | 2.60 |
EV / EBITDA | 5.28 |
EV / EBIT | 10.50 |
EV / FCF | 12.63 |
Financial Position
The company has a current ratio of 0.49, with a Debt / Equity ratio of 1.31.
Current Ratio | 0.49 |
Quick Ratio | 0.43 |
Debt / Equity | 1.31 |
Debt / EBITDA | 3.28 |
Debt / FCF | 7.97 |
Interest Coverage | 2.75 |
Financial Efficiency
Return on equity (ROE) is 9.71% and return on invested capital (ROIC) is 5.42%.
Return on Equity (ROE) | 9.71% |
Return on Assets (ROA) | 4.65% |
Return on Invested Capital (ROIC) | 5.42% |
Return on Capital Employed (ROCE) | 8.11% |
Revenue Per Employee | 490,323 |
Profits Per Employee | 54,378 |
Employee Count | 3,854 |
Asset Turnover | 0.30 |
Inventory Turnover | n/a |
Taxes
In the past 12 months, FRA:COG has paid 54.42 million in taxes.
Income Tax | 54.42M |
Effective Tax Rate | 19.73% |
Stock Price Statistics
The stock price has decreased by -4.27% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -4.27% |
50-Day Moving Average | 43.33 |
200-Day Moving Average | 44.13 |
Relative Strength Index (RSI) | 33.51 |
Average Volume (20 Days) | n/a |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, FRA:COG had revenue of EUR 1.89 billion and earned 209.57 million in profits. Earnings per share was 4.95.
Revenue | 1.89B |
Gross Profit | 944.68M |
Operating Income | 468.38M |
Pretax Income | 275.82M |
Net Income | 209.57M |
EBITDA | 924.98M |
EBIT | 468.38M |
Earnings Per Share (EPS) | 4.95 |
Balance Sheet
The company has 156.81 million in cash and 3.06 billion in debt, giving a net cash position of -2.90 billion.
Cash & Cash Equivalents | 156.81M |
Total Debt | 3.06B |
Net Cash | -2.90B |
Net Cash Per Share | n/a |
Equity (Book Value) | 2.34B |
Book Value Per Share | 47.56 |
Working Capital | -274.50M |
Cash Flow
In the last 12 months, operating cash flow was 763.71 million and capital expenditures -379.80 million, giving a free cash flow of 383.92 million.
Operating Cash Flow | 763.71M |
Capital Expenditures | -379.80M |
Free Cash Flow | 383.92M |
FCF Per Share | n/a |
Margins
Gross margin is 49.99%, with operating and profit margins of 24.79% and 11.09%.
Gross Margin | 49.99% |
Operating Margin | 24.79% |
Pretax Margin | 14.60% |
Profit Margin | 11.09% |
EBITDA Margin | 48.95% |
EBIT Margin | 24.79% |
FCF Margin | 20.32% |
Dividends & Yields
This stock pays an annual dividend of 2.40, which amounts to a dividend yield of 5.93%.
Dividend Per Share | 2.40 |
Dividend Yield | 5.93% |
Dividend Growth (YoY) | 3.42% |
Years of Dividend Growth | 20 |
Payout Ratio | 48.44% |
Buyback Yield | 2.37% |
Shareholder Yield | 8.30% |
Earnings Yield | 12.63% |
FCF Yield | 23.13% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | |
Lynch Upside | |
Graham Number | |
Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
FRA:COG has an Altman Z-Score of 1.06 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 1.06 |
Piotroski F-Score | 7 |